BNP Paribas Financial Markets’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-23,663
| Closed | -$460K | – | 3834 |
|
|
2018
Q1 | $460K | Sell |
23,663
-15,723
| -40% | -$306K | ﹤0.01% | 1743 |
|
|
2017
Q4 | $656K | Buy |
39,386
+153
| +0.4% | +$2.55K | ﹤0.01% | 1696 |
|
|
2017
Q3 | $796K | Buy |
39,233
+15,735
| +67% | +$319K | ﹤0.01% | 1534 |
|
|
2017
Q2 | $378K | Buy |
23,498
+8,469
| +56% | +$136K | ﹤0.01% | 1798 |
|
|
2017
Q1 | $190K | Buy |
15,029
+1,588
| +12% | +$20.1K | ﹤0.01% | 1898 |
|
|
2016
Q4 | $178K | Buy |
13,441
+2,099
| +19% | +$27.8K | ﹤0.01% | 1927 |
|
|
2016
Q3 | $269K | Sell |
11,342
-22,866
| -67% | -$542K | ﹤0.01% | 1586 |
|
|
2016
Q2 | $986K | Buy |
34,208
+10,968
| +47% | +$316K | ﹤0.01% | 1175 |
|
|
2016
Q1 | $744K | Buy |
23,240
+9,564
| +70% | +$306K | ﹤0.01% | 1093 |
|
|
2015
Q4 | $585K | Sell |
13,676
-1,136
| -8% | -$48.6K | ﹤0.01% | 1293 |
|
|
2015
Q3 | $522K | Buy |
14,812
+8,847
| +148% | +$312K | ﹤0.01% | 1333 |
|
|
2015
Q2 | $274K | Buy |
5,965
+573
| +11% | +$26.3K | ﹤0.01% | 1577 |
|
|
2015
Q1 | $253K | Buy |
5,392
+3,939
| +271% | +$185K | ﹤0.01% | 1495 |
|
|
2014
Q4 | $46K | Sell |
1,453
-7,762
| -84% | -$246K | ﹤0.01% | 1703 |
|
|
2014
Q3 | $218K | Buy |
9,215
+4,878
| +112% | +$116K | ﹤0.01% | 1535 |
|
|
2014
Q2 | $130K | Buy |
4,337
+1,123
| +35% | +$33.7K | ﹤0.01% | 1599 |
|
|
2014
Q1 | $84K | Buy |
3,214
+2,327
| +262% | +$60.9K | ﹤0.01% | 1720 |
|
|
2013
Q4 | $22.3K | Sell |
887
-17,767
| -95% | -$447K | ﹤0.01% | 1789 |
|
|
2013
Q3 | $382K | Sell |
18,654
-5,450
| -23% | -$112K | ﹤0.01% | 1487 |
|
|
2013
Q2 | $481K | Buy |
+24,104
| New | +$481K | ﹤0.01% | 1359 |
|